Candidate Gene for the Chromosome 1 Familial Alzheimer's Disease Locus
Science1995Vol. 269(5226), pp. 973–977
Citations Over TimeTop 1% of 1995 papers
Ephrat Levy‐Lahad, Wilma Wasco, Parvoneh Poorkaj, Donna Romano, Junko Oshima, Warren H. Pettingell, Chang-En Yu, P. D. Jondro, Stephen D. Schmidt, Kai Wang, Annette C. Crowley, Ying‐Hui Fu, Suzanne Y. Guénette, David J. Galas, Ellen Nemens, Ellen M. Wijsman, Thomas D. Bird, Gerard D. Schellenberg, Rudolph E. Tanzi
Abstract
A candidate gene for the chromosome 1 Alzheimer's disease (AD) locus was identified (STM2). The predicted amino acid sequence for STM2 is homologous to that of the recently cloned chromosome 14 AD gene (S182). A point mutation in STM2, resulting in the substitution of an isoleucine for an asparagine (N141l), was identified in affected people from Volga German AD kindreds. This N141l mutation occurs at an amino acid residue that is conserved in human S182 and in the mouse S182 homolog. The presence of missense mutations in AD subjects in two highly similar genes strongly supports the hypothesis that mutations in both are pathogenic.
Related Papers
- → Desmoplakin missense and non-missense mutations in arrhythmogenic right ventricular cardiomyopathy: Genotype-phenotype correlation(2017)91 cited
- → Molecular Mechanisms and Clinical Phenotypes of GJB2 Missense Variants(2023)15 cited
- → Missense mutations and the magnitude of functional deficit: the example of factor IX(1992)19 cited
- → Regional missense constraint improves variant deleteriousness prediction(2017)391 cited
- → Evaluation of cancer related missense mutations in CENPH(2019)